BioSyent Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | BioSyent Inc.

BioSyent Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Grandeur Peak Global Advisors LLC

728,093

5.01%

-39,700

0.17%

04/30/2018

Manulife Asset Management Ltd.

186,400

1.28%

04/30/2018

CI Investments, Inc.

114,600

0.79%

114,600

06/30/2017

Fidelity Management & Research Co.

82,677

0.56%

66,591

07/31/2018

1832 Asset Management LP

13,041

0.09%

2,582

12/31/2017

View Profile

Address	170 Attwell Drive Toronto Ontario M9W 5Z5 Canada
Employees	-
Website	http://www.biosyent.com
Updated	07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.